case_images: PMC10693465_01
case_images: Change in platelet count and serum LDH and ADAMTS13 levels over time with different treatment modalities.
case_images: CRIHEM2023-8173903.001.jpg
case_images: PMC10693465_01_CRIHEM2023-8173903.001.jpg
case_images: fig1
case_images: On day 42, one week after initiating plasma cell-directed therapy with bortezomib, the patient achieved complete ADAMTS13 remission with ADAMTS13 levels rising to 57% (Figure 1).